<DOC>
	<DOCNO>NCT01998113</DOCNO>
	<brief_summary>Since publication New England Journal Medicine ( NEJM ) 2000 Langer 's trial comparing glyburide vs insulin treatment gestational diabetes mellitus ( GDM ) , additional study oral agent treatment GDM publish ( observational , randomize control trial ( RCT ) , trial use drug like metformin ) . Some meta-analysis summarize evidence publish : Nicholson 2009 ( include 4 RCT address different drug ) , Dhulkotia 2010 ( include 6 RCT address different drug , meta-analysis combine drug altogether ) , Gui 2013 ( include 5 RCT address metformin v insulin ) . Oral agent increasingly use treatment GDM . Investigators aim update evidence RCTs compare glyburide metformin v insulin summarize evidence use meta-analysis tool . Specifically , investigator aim produce distinct meta-analyses one three drug comparison . This information available literature since recent systematic review specifically deal oral agent treatment GDM address single drug comparison ( Gui 2013 ) combine different drug comparison single meta-analysis ( Dhulkotia 2010 )</brief_summary>
	<brief_title>Glyburide Metformin Treatment Gestational Diabetes Mellitus . Systematic Review</brief_title>
	<detailed_description>This project involve systematic review RCT addressing use glyburide metformin treatment GDM . The review include RCT compare drug versus insulin make direct comparison two oral agent pregnant woman GDM . Investigators pre-specified series maternal fetal outcomes interest . A comprehensive electronic search strategy complement search bibliography relevant study contact author eligible study regard issue study design information primary outcome . The risk bias include study analyze information use perform sensitivity analysis . If possible , data original study pool relative risk dichotomous outcome mean difference continuous outcome . Heterogeneity explore analysis . Analyses undertaken use fixed effect model repeat use random effect model case substantial heterogeneity . Results systematic review publish follow PRISMA guidance .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Glyburide</mesh_term>
	<criteria>RCT GDM compare Glyburide v Insulin , Metformin v Insulin Metformin v Glyburide data fetal and/or maternal outcome full text available significant overlap article group</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>gestational diabetes mellitus</keyword>
	<keyword>glyburide</keyword>
	<keyword>metformin</keyword>
	<keyword>oral agent</keyword>
	<keyword>insulin</keyword>
	<keyword>outcome</keyword>
</DOC>